Dan Soffer

Internist and lipidologist at University of Pennsylvania. Aging soccer player. Dad and husband. President National Lipid Association (2023/24)

[Circulation @CircAHA]

#OriginalResearch Both 'weekend warrior' and regular exercise patterns lower cardiometabolic risk. The total volume of physical activity, rather the pattern is most relevant for risk of future disease. @ShinoKany @shaan_khurshid https://t.co/ltZRvBnP6H

[Iftikhar J. Kullo @iftikhar_kullo]

A timely symposium on Racial Disparities in Cardiovascular Disease Risk sponsored by @UABCardiology

Honored to be invited

My talk will be on ‘Race and cardiovascular risk. Is it genes or environment?’

[AHA Science @AHAScience]

Save these dates for #EpiLifestyle25! New Orleans is the place to be for insightful discussions, leading epidemiology and lifestyle science, and networking with colleagues old and new.

[Dan Soffer @dan_soffer]

@Drlipid I have noticed increasing use of Lpa testing in patients referred to me in the last year. I think #s are improving @ArchnaBajajMD @DrSafarova @Drlipid

[Dan Soffer @dan_soffer]

Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System, JCL in press.

https://t.co/P1Qqtj9vsr

[Archna Bajaj @ArchnaBajajMD]

Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System. @dan_soffer

https://t.co/PDQnLm2XyO

[Archna Bajaj @ArchnaBajajMD]

Real-world experience of inclisiran at UPenn, now in JCL: https://t.co/xxPsdsYmIt
@dan_soffer @MWilkinsonMD

[Cardiovascular Institute of Philadelphia @cvi_phila]

Join us for Beyond the Basics: Approach to Lipoprotein(a) Management, a complimentary dinner program with CVI and PLAC! October 16, at the Loews Philadelphia Hotel. https://t.co/B2AGM6NfNx

[NYU CVD Prevention @NYUCVDPrevent]

In this @medscapeCME, #CardioRheumatology experts Dr. Michael Garshick and Dr. Brittany Weber share insights on assessing inflammatory risk and the latest treatments to improve outcomes for patients at risk of cardiovascular events.

@nyugrossman @RobMagyar @garshick @Bweber04

[Dan Soffer @dan_soffer]

Now available @nationallipid @MarlysLPA @MBBoffa @Lpa_Doc @hillypaige2 @PennCVFellows @PennCardiology @ProfKausikRay @JohnKastelein @ArsenaultBenoit @Drlipid

[Priya Pillai @PriyaPillaiMD]

Thanks Dr. Kulkarni for the opportunity. It’s always fun to write about lipids :)

[National Lipid Association @nationallipid]

📄#SourceSaturday: Our Practical Recommendations in the Management of CV Diseases
Check out this easy breakdown!

🔗Download the infographic https://t.co/aFtp8xLtCW
#LipidXcellence #CholesterolMonth

[Family Heart Foundation @FamilyHeartFdn]

We’re just 10 DAYS away from thought-provoking sessions and impactful discussion at the #FamilyHeartSummit24. Wave hi if we’ll see you there! 👋

[Keith C. Ferdinand, MD, FACC, FAHA, FNLA @kcferdmd]

I have had the pleasure of working with @TinaKReddy and team to highlight the importance of public health measures and team-based care in addressing the disproportionate burden of resistant hypertension in US Black adults. See our article here!
https://t.co/7BE0v0POQi

[Thomas Dayspring @Drlipid]

Lipidaholics - just what you are all waiting for - another podcast of yours truly - this time interviewed by a pharmacist, Dr Tamara Ruggles - As usual I had a lot of fun - Visit and hopefully enjoy at https:// https://t.co/0S4OI3vn61 @nationallipid @society_eas @escardio @atherosociety @TheFHFoundation

[Borge G Nordestgaard @BNordestgaard]

Anne Langsted and I wrote a quick and comprehensive ABC on "Lipoprotein(a) and cardiovascular disease", just published in The Lancet: https://t.co/GI9w12q0ZN
As 1 in 5 have this the most common genetic cause of CVD, it is high time to measure in all at CVD risk. Treatment soon:

[Michael Wilkinson @MWilkinsonMD]

@nationallipid recently made recommendations to consider lipoprotein apheresis in certain patients with elevated Lp(a):

https://t.co/joapiBDlWx

@MarlysLPA @MBBoffa @kcferdmd @ErinMichos @DrSafarova @dan_soffer @PamTaubMD @CBallantyneMD @grsoffer @hsbhatia @DrMichaelShapir

[Michael Wilkinson @MWilkinsonMD]

Lp(a) is actionable today, & for some patients this includes treatment with lipoprotein apheresis

https://t.co/7hAOFvBflY

@MBBoffa @MarlysLPA @kcferdmd @ErinMichos @DrSafarova @nationallipid @ASPCardio @dan_soffer @CBallantyneMD @PamTaubMD @DrMichaelShapir @lipiddoc @UCSDHealth

[Dan Soffer @dan_soffer]

@DudzLightLime @carolkirkpat3 @theproof @NutritionMadeS3 @Drlipid @DudzLightLime that is not correct at all. I would suggest reading the paper or waiting for the finished infographic (apologies for inadvertent release of unedited version which was taken down from site when we realized the mistake).

[Dan Soffer @dan_soffer]

@theproof @carolkirkpat3 @NutritionMadeS3 @Drlipid that is why we need fabulous science communication experts like yourself to move the right message. Happy to discuss sometime why guidelines do not match expert care. This issue should be right in your wheelhouse